Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Effecty vs MediRX

By GLP-1 ScorecardUpdated

Effecty
Site position #21

Higher grade

MediRX
Site position #226

Lower grade

Score comparison

Effecty has the higher recorded score — 83.7/100 to 66.1/100.

Effecty grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mid-market pricing offset by brand-name access and LegitScript verification, all 50 states.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueEffecty +16
80
64
Dose & formulationEffecty +7
84
77
Clinical oversightEffecty +3
85
82
Labs & monitoringEffecty +31
84
53
FulfillmentEffecty +14
87
73
Contract termsEffecty +66
86
20
Effecty · top barMediRX · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricEffectyMediRX
WeighScore83.7/10066.1/100
GradeBC
Site position#21#226
Semaglutide$160/mo$149/mo (compounded)
Tirzepatide$240/mo$199/mo (compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessYesYes
Oral / sublingualNot confirmedNot confirmed
Effecty

Site position #21 · B

Strengths

  • Brand-name access
  • LegitScript-verified, all 50 states
  • Both molecules

What to consider

  • Higher pricing ($160/$240)
  • Injection-only
  • Not a value leader
MediRX

Site position #226 · C

Strengths

  • LegitScript Certified — a meaningful trust signal for an online pharmacy
  • Named operating entity disclosed (MediRX, Inc., Wyoming)
  • Care and pharmacy fulfillment run on OpenLoop Health's licensed network
  • Low promotional first-month pricing — semaglutide first month as low as $70

What to consider

  • Doesn't publish the exact states it serves; telehealth rules vary by state
  • Ongoing monthly price rises after the promotional first month
  • Compounded semaglutide and tirzepatide injections — limited oral options
  • Specific compounding pharmacies aren't named beyond the OpenLoop network

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard